Why Invitae’s Q4 Results Didn’t Fire Up Investors

Invitae (NYSE: NVTA) delivered a sizzling performance in 2020, with its shares skyrocketing 159%. That sizzle fizzled somewhat last month, though, after the medical genetics company announced a dilution-causing stock offering.The company reported its fourth-quarter results afterRead MoreMarketsMarkets Feed